<DOC>
	<DOCNO>NCT02679001</DOCNO>
	<brief_summary>This six month non-interventional , observational , post-marketing , multi-center local study evaluate difference use corticosteroid RA participant receive TCZ TNF-inhibitor , participant discontinue use TNF-inhibitor first biological treatment .</brief_summary>
	<brief_title>A Comparative Study Observe Effect Concomitant Use Corticosteroid Treatment Rheumatoid Arthritis ( RA ) Participants Who Are Treated With Tumor Necrosis Factor ( TNF ) Inhibitor Tocilizumab ( TCZ ) Their Second Biological Treatment .</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>At least 18 year age . With diagnosis moderate severe RA accord revise ( 1987 ) American College Rheumatology ( ACR ) criterion 2010 ACR/ European League Against Rheumatism ( EULAR ) RA classification criterion . Have insufficient response intolerance first TNFinhibitor ( include biosimilars TNFinhibitors ) . The treat physician make decision commence TCZ TNFinhibitor treatment . Participants need Disease Activity Score ( DAS ) 28 assessment initiation second biological treatment . Have give oral write information study objection data concern him/her subject computerize data processing , give informed consent . Have one TNFinhibitor prior enrolment visit . Have biological treatment TNFinhibitors . Participants continuously treat per oral corticosteroid indication RA ( baseline ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>